A patient is bleeding during a transfusion; how should the bleeding be managed?

Management of Bleeding During Transfusion

Immediately stop the transfusion, maintain IV access with normal saline, control obvious bleeding points with direct pressure, secure large-bore IV access, initiate your institution's massive hemorrhage protocol, and begin resuscitation with warmed blood products while aggressively correcting coagulopathy, hypothermia, and acidosis. 1

Immediate Actions (First 5-10 Minutes)

When a patient bleeds during transfusion, execute these steps simultaneously:

1. Stop and Assess

• Stop the current transfusion immediately but maintain IV access with normal saline 1
• Perform rapid clinical assessment: skin color, heart rate, blood pressure, capillary refill, conscious level 1
• Look for obvious blood loss (on clothes, floor, drains) and signs of internal bleeding 1
• If the patient is conscious, talking, and has a peripheral pulse present, blood pressure is adequate for now 1

2. Secure Access and Control Bleeding

• Control obvious bleeding points with direct pressure, tourniquets, or hemostatic dressings 1
• Establish large-bore IV access (largest possible, including 8-Fr central access if needed; consider intraosseous or surgical venous access if peripheral fails) 1
• Administer high-flow oxygen 1

3. Activate Massive Hemorrhage Protocol

Your institution must have a major hemorrhage protocol—activate it immediately 1. This protocol should mobilize:

• Blood bank for rapid product delivery
• Surgical team for potential hemorrhage control
• Laboratory for stat testing
• Designated team roles (team leader, communications lead, blood product runner) 1

Laboratory Assessment

Draw baseline labs immediately 1:

• Full blood count (FBC)
• Prothrombin time (PT)
• Activated partial thromboplastin time (aPTT)
• Clauss fibrinogen (NOT derived fibrinogen—it's misleading) 1
• Type and cross-match
• Point-of-care testing (TEG or ROTEM if available) 1

Monitor these parameters early and frequently 2, including temperature, biochemistry, and coagulation profiles to define critical derangements.

Resuscitation Strategy

Blood Product Administration

Use warmed blood and blood components for fluid resuscitation—not crystalloids 1. The most recent guideline evidence supports:

Transfusion Ratios: Implement ratio-based protocols with no fewer than 4 units of fresh frozen plasma (FFP) and 1 adult unit of platelets for every 8 units of red blood cells 2. Current evidence supports balanced ratios between 1:1:1 and 1:1:2 (plasma:platelets:RBCs) 3.

Blood Product Priority by Availability:

1. Blood group O (quickest)
2. Group-specific blood
3. Cross-matched blood 1

Actively warm the patient and ALL transfused fluids using approved blood warming equipment with visible thermometer and audible warning 1. This is critical—hypothermia exacerbates coagulopathy.

Coagulopathy Management

The coagulopathy in massive hemorrhage is multifactorial—not just dilutional 1, 4. Address:

Dilutional Coagulopathy: Prevent by early FFP infusion 1. Fibrinogen levels below 1 g/L are insufficient; target >1.5 g/L 1.

Consumptive Coagulopathy: Particularly common in trauma, obstetric hemorrhage, and sepsis 1. Manage with aggressive component therapy guided by laboratory results and point-of-care testing.

Hyperfibrinolysis: Consider tranexamic acid 1g IV over 10 minutes, followed by 1g over 8 hours if administered within 3 hours of bleeding onset 1, 2. This is particularly relevant in trauma and obstetric hemorrhage 2.

Physiological Targets

Do NOT aim for normal blood pressure initially—focus on restoring organ perfusion 1. Avoid vasopressors during active bleeding 1.

Once bleeding is controlled, aggressively normalize:

• Blood pressure
• Acid-base status
• Temperature
• Coagulation parameters 1

Definitive Management

Surgery must be considered early 1. Damage control surgery may be necessary—interrupt surgery to control bleeding, then correct abnormal physiology afterward 1.

Consider:

• Rapid imaging (ultrasound, CT) if patient is stable enough 1
• Cell salvage autotransfusion 1
• Radiological interventions for hemorrhage control

Post-Resuscitation Care

After bleeding control 1:

• Admit to critical care for monitoring
• Monitor coagulation, hemoglobin, blood gases, and wound drains
• Start venous thromboprophylaxis as soon as possible—patients rapidly develop a prothrombotic state after massive hemorrhage 1
• Consider temporary IVC filtration if needed 1

Critical Pitfalls to Avoid

1. Never use derived fibrinogen—only Clauss fibrinogen is reliable 1
2. Never warm blood with improvised methods (warm water, microwave, radiator)—use only approved warming equipment 1
3. Don't give prophylactic calcium—citrate toxicity is self-limiting and calcium administration is dangerous 5
4. Don't delay surgical consultation—hemorrhage control is paramount 1
5. Don't use recombinant factor VIIa (rFVIIa)—it is not recommended 2

The 2021 ESICM guideline 6 emphasizes that this is a dynamic, complex process requiring multidisciplinary coordination. The 2024 Australian guideline 2 reinforces that major hemorrhage protocols should be standard of care in all institutions managing critical bleeding.